Comments
Loading...

Lipocine

LPCNNASDAQ
Logo brought to you by Benzinga Data
$5.01
0.183.73%
At Close: -
$4.75
-0.26-5.19%
After Hours: Sep 17, 8:27 AM EDT
15 minutes delayed
Consensus Rating1
Overweight
Highest Price Target1
$33.00
Lowest Price Target1
$33.00
Consensus Price Target1
$33.00

Lipocine (NASDAQ:LPCN) Stock, Analyst Ratings, Price Targets, Forecasts

Lipocine Inc has a consensus price target of $33 based on the ratings of 1 analysts. The high is $33 issued by Cantor Fitzgerald on July 27, 2023. The low is $33 issued by Cantor Fitzgerald on July 27, 2023. The 1 most-recent analyst ratings were released by Cantor Fitzgerald on July 27, 2023, respectively. With an average price target of $33 between Cantor Fitzgerald, there's an implied 594.74% upside for Lipocine Inc from these most-recent analyst ratings.

Analyst Rating and Forecast
12345
4.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for Lipocine

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Lipocine (LPCN) stock?

A

The latest price target for Lipocine (NASDAQ:LPCN) was reported by Cantor Fitzgerald on July 27, 2023. The analyst firm set a price target for $33.00 expecting LPCN to rise to within 12 months (a possible 594.74% upside). 0 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Lipocine (LPCN)?

A

The latest analyst rating for Lipocine (NASDAQ:LPCN) was provided by Cantor Fitzgerald, and Lipocine reiterated their overweight rating.

Q

When was the last upgrade for Lipocine (LPCN)?

A

There is no last upgrade for Lipocine

Q

When was the last downgrade for Lipocine (LPCN)?

A

There is no last downgrade for Lipocine.

Q

When is the next analyst rating going to be posted or updated for Lipocine (LPCN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lipocine, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lipocine was filed on July 27, 2023 so you should expect the next rating to be made available sometime around July 27, 2024.

Q

Is the Analyst Rating Lipocine (LPCN) correct?

A

While ratings are subjective and will change, the latest Lipocine (LPCN) rating was a reiterated with a price target of $0.00 to $33.00. The current price Lipocine (LPCN) is trading at is $4.75, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch